Immediate Impact
1 by Nobel laureates 1 from Science/Nature 59 standout
Citing Papers
Targeting immunogenic cell stress and death for cancer therapy
2024 Standout
Hot and cold tumors: Immunological features and the therapeutic strategies
2023 Standout
Works of Robert DeJong being referenced
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Robert DeJong | 49 | 39 | 197 | 272 | 157 | 5 | 371 | |
| Javier Larrache | 32 | 19 | 150 | 164 | 167 | 8 | 388 | |
| Kathryn Ottolino‐Perry | 19 | 11 | 103 | 259 | 175 | 9 | 345 | |
| Nagarajan Ramesh | 85 | 7 | 184 | 231 | 146 | 9 | 344 | |
| Michael Lanuti | 35 | 5 | 161 | 248 | 114 | 8 | 369 | |
| Sabari Vallath | 18 | 27 | 161 | 103 | 154 | 8 | 343 | |
| Abhirami A. Ananth | 54 | 26 | 63 | 134 | 248 | 8 | 410 | |
| Niek V. Henriquez | 26 | 10 | 232 | 109 | 140 | 6 | 407 | |
| Helen C. Nauts | 21 | 52 | 82 | 71 | 122 | 6 | 356 | |
| Steve Albelda | 24 | 18 | 88 | 100 | 100 | 6 | 358 | |
| D R Herbold | 46 | 12 | 132 | 103 | 37 | 7 | 407 |
All Works
Loading papers...